One of the obstacles to the development of Poland’s clinical research market is due to be removed next month, according to local consultancy firm Polish Market Research.
Recent European legislation designed to increase the number of children in clinical trials has had a positive impact in ensuring that paediatric patients are included in medicine testing.
PharmaForm's new EPAS particle engineering technology, launched at this year's AAPS in Atlanta, US, may help drugmakers improve the solubility of insoluble actives without some of the costly and time consuming processing steps used by traditional...
US company Smithers Group has launched a formulation services company to tap into the emerging trend towards outsourcing of drug development among pharmaceutical companies.
A UK development think-tank has warned against a knee-jerk reaction against conducting clinical trials in India, following the revelation a few weeks ago that dozens of children had lost their lives in studies conducted at a contract research facility.
Alpharma moved a step closer to bringing its morphine product Embeda to market after a US Food and Drug Administration advisory panel agreed that it is less susceptible to abuse than other opioid analgesic products.
New Zealand has approved clinical trials of Living Cell Technologies (LCT) type 1 diabetes treatment, which uses porcine cells encapsulated in a seaweed based gel.
Demand for glycerin as an ingredient in pharmaceuticals, personal care and other products is expected to show brisk growth out 2015, when demand around the world is expected to reach 3.39 billion pounds, according to market research firm Global Industry...
UPS is planning on building a new facility in Puerto Rico to help establish a reliable cold-chain delivery service, suggesting a brighter future for the island’s industry.
Cost cutting has sustained pharma profits in the faltering global economy, however top executives are starting to realise that reducing R&D capacity may not have been the smartest move in an era of weak pipelines and impending patent expiry, according...
Merck Serono has begun work on the expansion of its Swiss biotech facility, with the additional capacity being used to meet rising demand for Erbitux (cetuximab).
US company Irvine Pharmaceutical Services is gearing up to launch a new subsidiary company to provide fill-and-finish services for biopharmaceutical companies.
GlaxoSmithKline (GSK) has proposed that it will close its facility in Dartford, UK in 2013, as the loss of patents for key drugs makes its operation uneconomical.
A Californian appeals court ruling may have altered product liability in the state, which could lead to numerous court cases being brought against big pharma.
Robert Sexauer, CEO of biopharmaceuticals group RCP Therapeutics, says the R&D investment deal signed with FirstPoint Biotech shows the attractiveness of the firm’s nano-medical pipeline, particularly given the current economic climate.
Danish drugmaker Novo Nordisk has unveiled an ambitious plan to build an insulin plant in China, tapping into a major new market for diabetes treatments.
American Association of Pharmaceutical Scientist's (AAPS) president Dr Karen Habucky sets out the programme for the group's forthcoming annual meeting and exposition, which is being held in Atlanta, US between November 16- 20.
Ethex has initiated its third recall of the year as yet again the spectre of dangerous oversized tablets casts its shadow over the St Louis-headquartered company’s manufacturing operations.
Pfizer is likely to lose its crown as the world’s largest pharmaceutical company and by 2012 will be usurped by GlaxoSmithKline, according to a report from Urch Publishing.
Patheon’s European HQ is up and running to help manage the firm’s growing European operations, specifically its development and commercial service offerings provided by units in France, Italy and the UK.
US Marshals have entered Celsus Laboratories to seize 11 lots of heparin, which contain contaminated material from China according to the US Food and Drug Administration (FDA).
The world-reknowned Mayo Clinic has decided to shut down its Mayo Clinical Trial Services unit, saying it has been unable to compete in a marketplace shifting towards “low-cost, routine trials.”
Cambrex joined a number of its peers in the contract services sector by reporting pressure on third quarter sales and earnings, providing further evidence that outsourcing companies are not immune to the economic downturn.
Senator Chuck Grassley has written a letter to Andrew von Eschenbach alleging systemic mismanagement of employee pay and benefits at the US Food and Drug Administration (FDA).
Covidien is recalling half a million ReliOn single-use insulin syringes after it was uncovered that some had been mislabelled, creating the potential for fatal overdose.
Kendle International has posted impressive third quarter results, despite seeing a dramatic increase in the number of contract cancellations during the period.
The Indian government is planning on establishing pharmaceutical zones at major international airports to facilitate exports, according to local media reports.
Barrack Obama’s election as US president has been roundly welcomed by India’s generics sector, despite his somewhat contradictory desire to reduce the level of outsourcing but not "shy away" from globalisation.
The new MabDirect MM Fixed D column, launched by Denmark’s Upfront Chromatography, could be a boon for CMO’s and pilot plants working in the expanding bio-processing sector.
UK drug major GSK is cutting approximately 1,000 US sales jobs by the end of 2008 as it reorganizes to compete in the increasingly tough pharmaceutical market.
RCP Therapeutics, a developer of regenerative medicine, hopes that its new HQ in the UK will benefit from the country’s status as a financial centre and proximity to cost effective trial sites in Eastern Europe.
Delays to US ePedigree and serialization laws, which will now not be implemented until 2015, could provide an unexpected windfall for US software firm Systech International and its PES platform.
Following Barack Obama’s victory in the race to the White House, in-PharmaTechnologist.com examines what this could mean for the pharmaceutical industry.
Cost pressure and the increasing complexity of trials is forcing drugmakers to increasingly turn to outsourcing experts for clinical development, according to a Kalorama Information report.
Caraco Pharmaceutical Laboratories, in which India’s Sun Pharmaceuticals holds a 76 per cent stake, has joined the list of generics manufacturers issued with an FDA warning on quality control issues.
MonoSol Rx has entered into a partnership with Midatech to develop new drug formulations using the companies’ respective expertise in thin film delivery and biocompatible nanocells.
An expansion of pilot plant facilities at its operations in Aurangabad, India will help Albany Molecular Research (AMRI) strengthen its position in the Asian drug development sector, according to CEO Thomas D’Ambra.
NeoStem has agreed to acquire China Biopharmaceuticals Holdings in an attempt to capitalise on the manufacturing and marketing opportunities in the nation.
